Award
National Institute of Diabetes and Digestive and Kidney Diseases 5R01DK136520-03
Morning Light Treatment for Inflammatory Bowel Disease: A Pilot Clinical Trial
Recipient
University of Michigan at Ann Arbor
Award Amount
$312,000.00
Ceiling
$312,000.00
Awarded
July 16, 2025
Identifier
5R01DK136520-03
This award funds a pilot clinical trial to test morning light treatment for inflammatory bowel disease, focusing on patient outcomes and disease severity, supported by NIDDK.
Description
A research grant opportunity for a clinical trial testing morning light treatment for IBD, funded by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK). The project aims to evaluate the effects on patient-reported outcomes, clinician-rated disease severity, and gastrointestinal inflammation biomarker. The project duration is from September 1, 2023, to December 31, 2026.